Arrowgrass Capital Partners (US)’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-35,000	Closed	-$2.86M	–	238
2015 Q2	$2.86M	Buy	+35,000	New	+$2.86M	0.04%	143